查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2151929

自動胰島素輸注系統市場規模、佔有率和趨勢分析報告：按產品類型、糖尿病類型、年齡層、最終用途、地區和細分市場預測（2026-2033 年）

Automated Insulin Delivery Systems Market Size, Share & Trends Analysis Report By Product (Predictive Low Glucose Suspend System, Fully Closed Loop System), By Diabetes Type, By Age Group, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

自動胰島素輸注系統市場概述

全球自動胰島素給藥系統市場預計到 2025 年將擴大到 188 億美元，2026 年至 2033 年的複合年成長率為 16.3%。

北美市場佔據主導地位，預計到2025年將佔據40.7%的最大市場佔有率。自動胰島素輸注（AID）系統結合了胰島素幫浦、持續血糖監測（CGM）和軟體演算法，可根據血糖值資訊自動調節胰島素劑量。糖尿病負擔日益加重，對有效的胰島素管理解決方案的需求也隨之顯著成長。

根據國際糖尿病聯盟（IDF）的估計，到2024年，全球20至79歲的成年人中將有5.89億人患有糖尿病，並且預計未來幾十年這一數字將顯著成長。不斷擴大的患者群體，特別是那些需要強化胰島素治療的患者，為先進的胰島素輸注技術創造了日益成長的潛在用戶群體。

市場成長的主要驅動力之一是持續血糖監測 (CGM) 和整合糖尿病管理技術的日益普及。 CGM 整合是自動胰島素輸注 (AID) 實施的關鍵基礎，因為 CGM 提供 AID 演算法自動調整胰島素劑量所需的持續血糖資訊。美國糖尿病協會 (ADA) 發布的《2026 年治療指南》建議使用 CGM 治療胰島素的糖尿病患者，並將 AID 系統定位為現代糖尿病技術的關鍵組成部分。該指南將 AID 系統定義為“利用基於 CGM 數據的演算法調整胰島素劑量的技術”，這表明整合胰島素幫浦和 CGM 的系統在日常糖尿病管理中發揮著日益重要的作用。隨著 CGM 的普及和設備間互通性的提高，患者和醫護人員更容易獲得能夠實現胰島素劑量自動調整的整合解決方案。

臨床證據的累積以及輔助胰島素輸注系統（AID）在第1型糖尿病以外其他領域的應用不斷擴展，也推動了市場需求。雖然AID系統傳統上主要用於第1型糖尿病，但近期的臨床研究已證實其對接受胰島素治療的第二型糖尿病患者有效。一項發表於2025年《新英格蘭醫學日誌》的隨機臨床試驗顯示，接受胰島素治療並同時使用AID的2型糖尿病成年患者的糖化血紅蛋白（HbA1c）水平較繼續採用傳統胰島素給藥方式並配合持續血糖監測（CGM）的患者下降幅度更大。另一項2025年進行的臨床研究納入了305名2型糖尿病成年患者，結果顯示，使用AID 13週後，患者的平均HbA1c水平從8.2%降至7.4%。這些發現支持將AID技術推廣至更廣泛的胰島素治療患者群體，強化了其臨床應用的合理性。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：自動胰島素輸注系統市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 自動胰島素輸注系統市場分析工具

第4章：自動胰島素輸注系統市場：產品具體估算與趨勢分析

  • 自動胰島素輸注系統市場：產品特定趨勢分析
  • 自動胰島素輸注系統市場：產品展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 低血糖預測停止（PLGS）系統
  • 全封閉回路型（FCL）系統
  • 先進混合閉合迴路（AHCL）系統

第5章：自動胰島素輸注系統市場：依糖尿病類型分類的估算與趨勢分析

  • 自動胰島素輸注系統市場：依糖尿病類型分類的波動分析
  • 自動胰島素輸注系統市場：按糖尿病類型分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 1型糖尿病
  • 2型糖尿病

第6章：自動胰島素輸注系統市場：依年齡層別分類的估算與趨勢分析

  • 自動胰島素輸注系統市場：依年齡層別分類的趨勢分析
  • 自動胰島素輸注系統市場：依年齡層分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 兒童
  • 成年人和老年人

第7章：自動胰島素輸注系統市場：依最終用途分類的估算與趨勢分析

  • 自動胰島素輸注系統市場：依最終用途分類的趨勢分析
  • 自動胰島素輸注系統市場：依最終用途分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 醫院和診所
  • 居家照護環境
  • 其他

第8章：自動胰島素輸注系統市場：區域預測與趨勢分析

  • 區域儀錶板
  • 自動胰島素輸注系統區域市場波動分析
  • 自動胰島素輸注系統市場：區域預測與趨勢分析
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
    • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第9章 競爭情勢

  • 參與企業的分類
  • 主要公司簡介
    • Medtronic plc
    • Tandem Diabetes Care
    • Insulet Corporation
    • Ypsomed
    • Nikkiso Co., Ltd.
    • Beta Bionics, Inc.
    • Diabeloop
    • Medtrum GmbH
    • CamDiab
    • Sequel Med Tech, LLC
Product Code: GVR-4-68041-041-1

Automated Insulin Delivery Systems Market Summary

The global automated insulin delivery systems market size was valued at USD 5.7 billion in 2025 and is projected to grow from USD 6.5 billion in 2026 to USD 18.8 billion by 2033, at a CAGR of 16.3% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 40.7% in 2025. The automated insulin delivery (AID) systems combine an insulin pump, continuous glucose monitoring (CGM), and a software algorithm that uses glucose information to automatically adjust insulin delivery. The growing diabetes burden is creating a large underlying need for effective insulin-management solutions.

The International Diabetes Federation estimates that 589 million adults aged 20-79 years were living with diabetes globally in 2024, with the number projected to rise substantially over the coming decades. This expanding patient population, particularly people requiring intensive insulin therapy, provides a growing base of potential users for advanced insulin-delivery technologies.

A major factor supporting market growth is the increasing adoption of CGM and integrated diabetes technologies. CGM provides the continuous glucose information required for AID algorithms to automatically adjust insulin delivery, making CGM integration an important foundation for AID adoption. The American Diabetes Association's 2026 Standards of Care recommends CGM for people with diabetes using insulin and recognizes AID systems as a major component of modern diabetes technology. The guideline describes AID systems as technologies that use CGM-informed algorithms to modulate insulin delivery, demonstrating the increasing role of integrated pump-CGM systems in routine diabetes management. As CGM becomes more widely adopted and device interoperability improves, patients and healthcare professionals have greater access to integrated solutions capable of providing automated insulin adjustments.

Growing clinical evidence and expanding use of AID beyond type 1 diabetes are also strengthening market demand. Historically, AID systems were primarily associated with type 1 diabetes, but recent clinical studies have demonstrated benefits among insulin-treated people with type 2 diabetes. In a 2025 randomized clinical trial published in the New England Journal of Medicine, adults with insulin-treated type 2 diabetes who received AID experienced a greater reduction in HbA1c than those continuing their previous insulin-delivery method while using CGM. Another 2025 clinical study involving 305 adults with type 2 diabetes reported a reduction in average HbA1c from 8.2% to 7.4% after 13 weeks of AID use. These findings support the expansion of AID technology into a substantially broader insulin-treated population and strengthen the clinical rationale for adoption.

Global Automated Insulin Delivery Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global automated insulin delivery systems market report based on product, diabetes type, age group, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Predictive Low Glucose Suspend (PLGS) System
  • Fully Closed Loop (FCL) System
  • Advanced Hybrid Closed Loop (AHCL) System
  • Diabetes Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Age Group Outlook (Revenue, USD Million, 2021 - 2033)
  • Pediatric
  • Adult & Geriatric
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Homecare Settings
  • Others
  • Region Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Thailand
    • Australia
    • India
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Diabetes Type
    • 1.2.3. Age Group
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Diabetes Type outlook
    • 2.2.3. Age Group outlook
    • 2.2.4. End Use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Automated Insulin Delivery Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Automated Insulin Delivery Systems Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Automated Insulin Delivery Systems Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Automated Insulin Delivery Systems Market: Product Movement Analysis
  • 4.3. Automated Insulin Delivery Systems Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Predictive Low Glucose Suspend (PLGS) System
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Fully Closed Loop (FCL) System
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Advanced Hybrid Closed Loop (AHCL) System
    • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Automated Insulin Delivery Systems Market: Diabetes Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Automated Insulin Delivery Systems Market: Diabetes Type Movement Analysis
  • 5.3. Automated Insulin Delivery Systems Market by Diabetes Type Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Type 1 Diabetes
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Type 2 Diabetes
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Automated Insulin Delivery Systems Market: Age Group Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Automated Insulin Delivery Systems Market: Age Group Movement Analysis
  • 6.3. Automated Insulin Delivery Systems Market by Age Group Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Pediatric
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Adult & Geriatric
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Automated Insulin Delivery Systems Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Automated Insulin Delivery Systems Market: End Use Movement Analysis
  • 7.3. Automated Insulin Delivery Systems Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. Hospitals and Clinics
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Homecare Settings
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Automated Insulin Delivery Systems Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Regional Automated Insulin Delivery Systems Market Movement Analysis
  • 8.3. Automated Insulin Delivery Systems Market: Regional Estimates & Trend Analysis by Product & Diabetes Type
  • 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 8.5. North America
    • 8.5.1. North America Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. U.S.
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. U.S. Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Canada
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. Canada Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. Mexico Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Europe
    • 8.5.6. Europe Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. UK
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement scenario
      • 8.5.7.5. UK Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Germany
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Reimbursement scenario
      • 8.5.8.5. Germany Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.9. France
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Reimbursement scenario
      • 8.5.9.5. France Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.10. Italy
      • 8.5.10.1. Key Country Dynamics
      • 8.5.10.2. Competitive Scenario
      • 8.5.10.3. Regulatory Framework
      • 8.5.10.4. Reimbursement scenario
      • 8.5.10.5. Italy Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.11. Spain
      • 8.5.11.1. Key Country Dynamics
      • 8.5.11.2. Competitive Scenario
      • 8.5.11.3. Regulatory Framework
      • 8.5.11.4. Reimbursement scenario
      • 8.5.11.5. Spain Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.12. Denmark
      • 8.5.12.1. Key Country Dynamics
      • 8.5.12.2. Competitive Scenario
      • 8.5.12.3. Regulatory Framework
      • 8.5.12.4. Reimbursement scenario
      • 8.5.12.5. Denmark Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.13. Sweden
      • 8.5.13.1. Key Country Dynamics
      • 8.5.13.2. Competitive Scenario
      • 8.5.13.3. Regulatory Framework
      • 8.5.13.4. Reimbursement scenario
      • 8.5.13.5. Sweden Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.14. Norway
      • 8.5.14.1. Key Country Dynamics
      • 8.5.14.2. Competitive Scenario
      • 8.5.14.3. Regulatory Framework
      • 8.5.14.4. Reimbursement scenario
      • 8.5.14.5. Norway Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. Japan Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. China Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement scenario
      • 8.6.4.5. India Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement scenario
      • 8.6.5.5. South Korea Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Reimbursement scenario
      • 8.6.6.5. Australia Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Reimbursement scenario
      • 8.6.7.5. Thailand Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. Brazil Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement scenario
      • 8.7.3.5. Argentina Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Middle East & Africa
    • 8.8.1. Middle East & Africa Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Reimbursement scenario
      • 8.8.2.5. South Africa Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Reimbursement scenario
      • 8.8.3.5. Saudi Arabia Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Reimbursement scenario
      • 8.8.4.5. UAE Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Reimbursement scenario
      • 8.8.5.5. Kuwait Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Medtronic plc
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Product Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Tandem Diabetes Care
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Product Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Insulet Corporation
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Product Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. Ypsomed
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Product Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. Nikkiso Co., Ltd.
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Product Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. Beta Bionics, Inc.
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Product Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. Diabeloop
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Product Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. Medtrum GmbH
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Product Benchmarking
      • 9.2.8.4. Strategic Initiatives
    • 9.2.9. CamDiab
      • 9.2.9.1. Company Overview
      • 9.2.9.2. Financial Performance
      • 9.2.9.3. Product Benchmarking
      • 9.2.9.4. Strategic Initiatives
    • 9.2.10. Sequel Med Tech, LLC
      • 9.2.10.1. Company Overview
      • 9.2.10.2. Financial Performance
      • 9.2.10.3. Product Benchmarking
      • 9.2.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 4. Global Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 5. Global Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 6. Global Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 7. North America Automated Insulin Delivery Systems Market, by Country, 2021 - 2033 (USD Million)
  • Table 8. North America Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 9. North America Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 10. North America Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 11. North America Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 12. U.S. Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 13. U.S. Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 14. U.S. Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 15. U.S. Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 16. Canada Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 17. Canada Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 18. Canada Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 19. Canada Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 20. Mexico Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 21. Mexico Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 22. Mexico Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 23. Mexico Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 24. Europe Automated Insulin Delivery Systems Market, by Country, 2021 - 2033 (USD Million)
  • Table 25. Europe Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 26. Europe Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 27. Europe Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 28. Europe Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 29. UK Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 30. UK Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 31. UK Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 32. UK Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 33. Germany Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 34. Germany Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 35. Germany Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 36. Germany Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 37. France Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 38. France Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 39. France Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 40. France Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 41. Italy Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 42. Italy Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 43. Italy Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 44. Italy Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 45. Spain Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 46. Spain Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 47. Spain Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 48. Spain Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 49. Norway Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 50. Norway Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 51. Norway Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 52. Norway Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 53. Denmark Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 54. Denmark Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 55. Denmark Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 56. Denmark Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 57. Sweden Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 58. Sweden Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 59. Sweden Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 60. Sweden Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61. Asia Pacific Automated Insulin Delivery Systems Market, by Country, 2021 - 2033 (USD Million)
  • Table 62. Asia Pacific Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 63. Asia Pacific Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 64. Asia Pacific Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 65. Asia Pacific Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 66. China Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 67. China Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 68. China Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 69. China Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 70. Japan Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 71. Japan Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 72. Japan Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 73. Japan Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 74. South Korea Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 75. South Korea Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 76. South Korea Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 77. South Korea Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 78. Thailand Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 79. Thailand Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 80. Thailand Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 81. Thailand Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 82. Australia Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 83. Australia Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 84. Australia Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 85. Australia Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 86. India Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 87. India Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 88. India Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 89. India Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 90. Latin America Automated Insulin Delivery Systems Market, by Country, 2021 - 2033 (USD Million)
  • Table 91. Latin America Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 92. Latin America Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 93. Latin America Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 94. Latin America Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 95. Brazil Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 96. Brazil Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 97. Brazil Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 98. Brazil Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 99. Argentina Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 100. Argentina Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 101. Argentina Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 102. Argentina Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 103. MEA Automated Insulin Delivery Systems Market, by Country, 2021 - 2033 (USD Million)
  • Table 104. MEA Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 105. MEA Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 106. MEA Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 107. MEA Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 108. South Africa Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 109. South Africa Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 110. South Africa Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 111. South Africa Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 112. Saudi Arabia Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 113. Saudi Arabia Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 114. Saudi Arabia Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 115. Saudi Arabia Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 116. UAE Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 117. UAE Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 118. UAE Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 119. UAE Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 120. Kuwait Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 121. Kuwait Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 122. Kuwait Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 123. Kuwait Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig 1. Information procurement
  • Fig 2. Primary research pattern
  • Fig 3. Market research approaches
  • Fig 4. Value chain-based sizing & forecasting
  • Fig 5. Market formulation & validation
  • Fig 6. Automated insulin delivery systems market segmentation
  • Fig 7. Market driver analysis (Current & future impact)
  • Fig 8. Market restraint analysis (Current & future impact)
  • Fig 9. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig 10. Porter's Five Forces Analysis
  • Fig 11. Automated insulin delivery systems market, product outlook key takeaways (USD Million)
  • Fig 12. Automated insulin delivery systems market: product movement analysis (USD Million), 2025 & 2033
  • Fig 13. Predictive low glucose suspend (PLGS) system market estimates and forecasts, 2021-2033
  • Fig 14. Fully closed loop (FCL) system market estimates and forecasts, 2021-2033
  • Fig 15. Advanced hybrid closed loop (AHCL) system market estimates and forecasts, 2021-2033
  • Fig 16. Automated insulin delivery systems market, diabetes type outlook key takeaways (USD Million)
  • Fig 17. Automated insulin delivery systems market: diabetes type movement analysis (USD Million), 2025 & 2033
  • Fig 18. Type 1 Diabetes market estimates and forecasts, 2021-2033
  • Fig 19. Type 2 Diabetes market estimates and forecasts, 2021-2033
  • Fig 20. Automated insulin delivery systems market, age group outlook key takeaways (USD Million)
  • Fig 21. Automated insulin delivery systems market: age group movement analysis (USD Million), 2025 & 2033
  • Fig 22. Pediatric market estimates and forecasts, 2021-2033
  • Fig 23. Adult & geriatric market estimates and forecasts, 2021-2033
  • Fig 24. Automated insulin delivery systems market, end use outlook key takeaways (USD Million)
  • Fig 25. Automated insulin delivery systems market: end use movement analysis (USD Million), 2025 & 2033
  • Fig 26. Hospitals and clinics market estimates and forecasts, 2021-2033
  • Fig 27. Homecare settings market estimates and forecasts, 2021-2033
  • Fig 28. Others market estimates and forecasts, 2021-2033
  • Fig 29. Automated insulin delivery systems market, regional key takeaways (USD Million)
  • Fig 30. Automated insulin delivery systems market regional outlook, 2025 & 2033, USD Million
  • Fig 31. North America automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 32. U.S. automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 33. Canada automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 34. Mexico automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 35. Europe automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 36. UK automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 37. Germany automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 38. France automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 39. Italy automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 40. Spain automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 41. Denmark automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 42. Sweden automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 43. Norway automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 44. Asia Paciifc automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 45. Japan automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 46. China automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 47. India automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 48. Australia automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 49. South Korea automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 50. Thailand automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 51. Latin America automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 52. Brazil automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 53. Argentina automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 54. Middle East & Africa automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 55. South Africa automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 56. Saudi Arabia automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 57. UAE automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 58. Kuwait automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 59. List of key emerging company's/indication disruptors/innovators